---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-106804"
form_type: "8-K"
ticker: "HOWL"
cik: "0001785530"
company_name: "Werewolf Therapeutics, Inc."
filed_at: "2022-04-15T23:59:59+00:00"
generated_at: "2026-06-26T07:10:45.530042+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Werewolf Therapeutics secures $40M loan facility; director resigns

## Summary
- Up to $40M term loan from Pacific Western Bank: $20M available immediately, $20M contingent on FDA acceptance of two INDs by March 2023.
- Loan initially undrawn; interest at prime + 0.5% (floor 4.50%); interest-only until Amortization Date (Feb 2024, extendable), then 24-month amortization.
- Covenant requires raising $50M gross proceeds from equity or partnerships by Sept 30, 2023, and maintaining $20M unrestricted cash thereafter.
- Loan secured by personal property excluding IP; no prepayment penalty; success fee on certain corporate transactions.
- Director Sakae Asanuma resigned from board effective April 15, 2022.

## SEC filing metadata
- accession: 0001193125-22-106804
- form_type: 8-K
- ticker: HOWL
- cik: 0001785530
- company_name: Werewolf Therapeutics, Inc.
- filed_at: 2022-04-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785530/000119312522106804/0001193125-22-106804-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785530/000119312522106804/d349792d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-106804
- JSON: https://secwatch.observer/filing/0001193125-22-106804.json
- Plain text: https://secwatch.observer/filing/0001193125-22-106804.txt

## Key facts
- Executive change
  Sakae Asanuma resigned as Director at Werewolf Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On April 12, 2022, Sakae Asanuma submitted his resignation from the Board of Directors of the Company effective as of April 15, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1785530/000119312522106804/0001193125-22-106804-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.